(MENAFN- GlobeNewsWire - Nasdaq) Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify patients with a negative sentinel lymph ...
In the dynamic landscape of workflow automation, n8n is a powerful and versatile tool. However, there are instances where the existing nodes may not fully address your unique requirements. This is ...
TAMPA, Fla. (Oct. 22, 2025) — A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma patients who have a low risk ...
FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback